Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
- Status
- COMPLETED
- Phase
- N/A
A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination
- Status
- COMPLETED
- Phase
- NA
Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Ph I Ipilimumab Vemurafenib Combo in Patients With v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)
- Status
- TERMINATED
- Phase
- PHASE1
Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
HYPAZ: Hypertension Induced by Pazopanib
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of MGA271 in Refractory Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Does the Aid of MelaFind Affect Clinical Management Decisions
- Status
- COMPLETED
- Phase
- N/A
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Melanoma Risk Assessment & Tailored Intervention
- Status
- COMPLETED
- Phase
- NA